Respiratory secretions near the end of life

01OverviewDefinition, clinical context and the essential points that orientate the chapter.

Noisy upper-airway breathing is common as consciousness, swallowing and cough decline near death. Air passing through pooled saliva and bronchial fluid produces a rattling sound. The person may be too unconscious to experience it, although this cannot be assumed. Observe facial tension, agitation, respiratory effort and response to repositioning, and ask family what they are seeing and fearing.

The first task is to avoid diagnostic collapse. Sudden onset, choking, stridor, haemoptysis, pink froth, fever or new hypoxaemia suggests another mechanism. Examine the mouth and accessible airway, chest, fluid status and feeding history. Tests should be proportionate: a dying person comfortable with a typical rattle rarely benefits from radiography, while an unexpectedly deteriorating patient may have treatable aspiration or oedema.

Communication is active treatment. Say that swallowing is weakening, fluid is moving with each breath and the sound does not necessarily mean suffocation. Demonstrate the side or head-up position and explain why thirst is treated with mouth care rather than automatically increasing intravenous fluid. Invite relatives to participate in gentle lip and mouth care if they want, without making them responsible for clinical treatment.

Position the person laterally with the head supported, or elevate the head when respiratory mechanics require it. Reduce fluids or feeds that are not improving comfort and may be contributing, after an individual goals discussion. Avoid repeated deep suction; it is intrusive and fluid will often return. Gentle removal of material visible in the mouth may help, especially after vomiting or bleeding, with appropriate personal protection.

If secretion remains troublesome, choose one antimuscarinic. Glycopyrronium has limited central penetration and is often selected when delirium is a concern. Hyoscine butylbromide is another peripheral option; hyoscine hydrobromide crosses the blood-brain barrier and can add sedation or delirium. Response is uncertain, so prescribe an initial rescue and a reviewed 24-hour plan rather than automatically combining agents.

Antimuscarinic adverse effects matter even near death. Dry mouth can worsen discomfort, urinary retention can provoke agitation and ocular or cardiac effects may be relevant. Renal dysfunction can prolong glycopyrronium exposure, while hepatic or frailty considerations affect the whole medicine burden. If no improvement follows an adequate short trial, do not continue escalation simply to change the sound for observers.

Key points

Terminal respiratory secretion usually reflects pooled saliva and airway fluid when swallowing and coughing diminish; it does not necessarily mean choking.
First-line assessment checks distress, consciousness, airway, oxygenation and whether onset or associated features suggest oedema, infection, aspiration, obstruction or blood.
Explain the mechanism and uncertainty to family before medicine: the sound often troubles listeners more than an unconscious patient.
First-line management is side positioning or head elevation, gentle mouth care and review of hydration, feeding, nebulisers and other contributors.
Avoid routine deep suction; remove only visible accessible material when it is likely to relieve obstruction and does not add distress.
Antimuscarinics reduce production of new fluid and work better when started before secretions are extensive; they cannot clear existing pooled fluid.
Choose one agent using local guidance, comorbidity and availability, then review sound, patient comfort, mouth dryness, urine retention and delirium.
The gold-standard outcome is patient comfort and informed family understanding, not complete silence at the cost of anticholinergic toxicity.
If the patient appears distressed, treat pain, breathlessness, pulmonary oedema or infection as relevant rather than escalating antimuscarinic solely for volume.

02AetiologyUnderlying causes, associations and risk factors, with why each one matters.

Reduced swallowing

Diminished consciousness and bulbar weakness impair clearance of saliva and upper-airway fluid during the last hours or days.

Excess airway fluid

Infection, aspiration, tumour, tracheo-oesophageal fistula and pulmonary oedema increase respiratory tract fluid through distinct treatable mechanisms.

Iatrogenic contribution

Clinically assisted hydration, enteral feeding, repeated suction and poorly targeted nebulisation can increase fluid burden or secretion stimulation.

Airway obstruction

Tumour, clot, foreign material or thick mucus can create noisy turbulent airflow and requires more urgent mechanical assessment.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.

1
Loss of clearance reflex
Weaker swallowing and cough allow saliva and bronchial fluid to pool in the pharynx and central airways.
2
Turbulent airflow
Air moving through pooled fluid creates a rattling sound that can be loud without corresponding conscious distress.
3
Secretion production
Muscarinic signalling drives salivary and airway gland secretion, which antimuscarinic medicines can reduce prospectively but not remove retrospectively.
4
Fluid transudation
Cardiac failure, renal failure or excessive parenteral hydration increases pulmonary interstitial and alveolar fluid, requiring mechanism-specific treatment.
5
Family threat perception
The sound resembles choking and can produce intense caregiver distress even when reduced consciousness limits the patient's awareness.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.

Typical terminal secretion

Gradually increasing rattling in a deeply drowsy person with weak swallow, no focal distress and expected dying supports pooled upper-airway fluid.

Patient distress

Grimacing, agitation, accessory-muscle use or tachypnoea indicates discomfort requiring breathlessness, pain and cause assessment regardless of noise volume.

Pulmonary oedema

Pink froth, orthopnoea, widespread crackles and acute hypoxaemia suggest fluid in alveoli and a different treatment pathway.

Aspiration event

Abrupt cough, choking, hypoxaemia or focal chest change after eating, vomiting or feeding supports inhaled material.

Central obstructionRed flag

Stridor, distress and reduced air entry suggest tumour, clot, foreign material or mucus plug needing urgent airway assessment.

Family trauma response

Panic, repeated suction requests or statements that the person is drowning signal an immediate need for clear bedside explanation and support.

Red flags requiring action

Stridor, choking, inability to ventilate or acute cyanosis requires airway emergency assessment rather than a routine secretion prescription.
Pink frothy sputum, new orthopnoea, widespread crackles or haemodynamic change suggests pulmonary oedema and possible diuretic or acute treatment.
Fresh haemoptysis, a sentinel bleed or known vessel erosion requires catastrophic-haemorrhage planning and urgent oncology or respiratory review.
Fever, purulent sputum, new hypoxaemia or focal signs suggests infection or aspiration pneumonia and should be treated according to goals.
Distress, grimacing or tachypnoea requires pain and breathlessness assessment; the sound alone does not reveal the patient's experience.
Deep suction causes discomfort, bleeding and more secretion and should not be used routinely in an unconscious dying person.
Antimuscarinics can cause urinary retention, dry mouth, blurred vision and delirium, with greater concern in frailty and renal impairment.

05InvestigationsWhat to request, why it matters and how to interpret it.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
First-line comfort and airway observationFirst stepFirst line
Why
Assess consciousness, facial distress, breathing effort, airway patency, visible oral material, oxygenation and onset pattern.
Interpretation and limitations
A comfortable deeply unconscious person with typical gradual rattle needs little investigation; distress or obstruction changes urgency.
02
Focused chest and fluid examination
Why
Look for focal infection, wheeze, widespread oedema, effusion, heart failure, dehydration and recent feed or fluid changes.
Interpretation and limitations
Clinical mechanism determines whether diuresis, antibiotic, drainage or feed and hydration review is more useful than an antimuscarinic.
03
Medication and hydration review
Why
Identify clinically assisted fluid, enteral feed, nebuliser, anticholinergic burden and medicines causing dry mouth, delirium or retention.
Interpretation and limitations
Modify burdensome contributors and avoid stacking agents with the same toxicity when no patient-centred benefit is evident.
04
Proportionate chest imaging
Why
Investigate unexpected oedema, aspiration, infection, effusion or obstruction when the result can change goal-concordant treatment.
Interpretation and limitations
Imaging is not a routine requirement for a recognised comfortable dying pattern and should not disrupt family presence without likely benefit.
05
Bladder and bowel assessment
Why
Check retention and impaction when agitation appears or antimuscarinic treatment is being considered or escalated.
Interpretation and limitations
Treating retention or constipation may relieve distress and prevents its misclassification as pain or terminal agitation.
06
Time-limited treatment response
Why
Review positioning and a single antimuscarinic against patient comfort, secretion intensity and adverse effects within hours.
Interpretation and limitations
Continue only for meaningful benefit; patient comfort and family understanding are more important than an acoustically silent chest.

06Differential diagnosisRealistic alternatives and the features that help distinguish them.

Terminal upper-airway secretion

A gradually developing rattle in a deeply drowsy dying person without distress is most consistent with pooled secretions.

Pulmonary oedema

Pink froth, orthopnoea, diffuse fine crackles, oedema and acute hypoxaemia point to alveolar fluid rather than saliva alone.

Aspiration or infection

Cough, fever, focal signs, hypoxaemia and a feeding or swallowing event supports aspiration pneumonia or infected secretion.

Central airway obstruction

Stridor, monophonic wheeze, localised low flow and distress suggests tumour, clot or mucus plugging requiring urgent airway review.

Catastrophic bleeding

Gurgling with fresh blood, sentinel haemoptysis or rapid haemodynamic collapse requires a haemorrhage response rather than routine secretion care.

07ManagementImmediate care, first-line treatment, alternatives and escalation.

01Typical secretionExplain, reposition and review fluidFirst stepA dying person develops gradual noisy upper-airway breathing without acute obstruction or visible distress.

1Assess comfort and exclude sudden airway, bleeding, oedema or infection features and explain pooled secretion and swallowing change to family.
2Reposition laterally or head up, provide mouth care and review whether fluid, feed, nebulisation or repeated suction is increasing burden.
3If noise remains troubling, offer one individual antimuscarinic trial with a review time and monitor comfort, dry mouth, retention and delirium.

02Acute noisy breathingTreat the airway mechanismNoisy breathing begins suddenly or accompanies distress, stridor, hypoxaemia, blood or pink froth.

1Use ABCDE assessment, position appropriately, call urgent help and remove only visible accessible obstructing material while supporting oxygenation and ventilation.
2EscalationTreat aspiration, pulmonary oedema, haemorrhage, infection or tumour obstruction within the agreed escalation plan rather than waiting for antisecretory medicine.
3Provide symptom relief and family communication throughout and update the emergency plan after stabilisation or transition to comfort care.

03Antimuscarinic trialReduce new secretion without stacking toxicityPositioning and explanation are insufficient and reducing further secretion may plausibly improve comfort or family distress.

1Choose glycopyrronium, hyoscine butylbromide or another local first option according to delirium, retention, glaucoma, cardiac and organ-function risks.
2Give the patient-specific subcutaneous rescue and start a 24-hour infusion only when repeated need and route justify it, checking compatibility with other pump medicines.
3Review within hours, continue a responder and stop or change a non-responder rather than combining multiple anticholinergic agents blindly.

04Family supportTranslate the sound into an understandable planRelatives are frightened that the patient is choking, drowning or suffering.

1Acknowledge the sound is distressing, explain what is known about reduced swallowing and assess the patient with the family present when appropriate.
2Describe positioning, mouth care, medicine limits and signs of actual distress, and give relatives a simple role only if they want it.
3Revisit understanding after any change, provide a number to call and include the event in bereavement support if it remains traumatic.

Key medicines and prescribing safety3 treatments · regimens, roles and cautions

Reduces production of new salivary and airway secretion with limited central anticholinergic penetration.

Glycopyrronium for terminal respiratory secretion

Give 200 micrograms subcutaneously as needed, commonly every 4 hours under the local protocol, and use 600 to 1200 micrograms over 24 hours by continuous subcutaneous infusion when repeated doses help.

It cannot remove existing fluid; monitor severe dry mouth, urinary retention, tachycardia and visual symptoms, and reduce or seek advice in renal impairment.

Provides peripheral antimuscarinic reduction of new secretion and may be preferred where a compatible pump regimen exists.

Hyoscine butylbromide for secretion

A common palliative regimen is 20 mg subcutaneously as needed up to every 4 hours and 60 to 120 mg over 24 hours by continuous infusion when the local protocol selects it.

Review urinary retention, glaucoma, tachyarrhythmia, bowel obstruction and dry mouth; check concentration-specific compatibility and do not combine routinely with another antimuscarinic.

Reduces secretion and may add sedation when that effect is specifically desired in a distressed dying patient.

Hyoscine hydrobromide with central effects

Where the local guideline selects it, use 400 micrograms subcutaneously as needed, often every 4 hours, or a reviewed 24-hour infusion regimen with specialist confirmation of the total.

Crosses the blood-brain barrier and can worsen confusion, hallucinations, dry mouth, retention and visual disturbance; avoid reflex use in delirium.

08ComplicationsImportant consequences, why they occur and why they matter clinically.

Family distress

Misinterpreting rattle as drowning or choking can cause panic, traumatic memory, repeated suction requests and complicated grief.

Aspiration injury

Poor swallowing and vomiting can introduce gastric or oral content into distal airways, causing obstruction, pneumonitis or infection.

Medication adverse effects

Antimuscarinic treatment can worsen dry mouth, retention, visual symptoms, tachycardia and confusion without providing audible improvement.

Suction trauma

Deep suction may cause pain, bleeding, hypoxia, coughing and further secretion while offering only brief acoustic change.

Missed reversible pathology

Calling every noisy breath a death rattle can delay treatment of oedema, infection, aspiration, haemorrhage or airway obstruction.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.

Review patient comfort, respiratory effort and consciousness separately from the loudness of the secretion.
Reassess airway, oxygenation and chest signs after any sudden change, blood, vomiting or new distress.
Check mouth moisture, urine retention, bowel function, delirium, pulse and vision symptoms during antimuscarinic treatment.
Record agent, rescue doses, 24-hour infusion, response and compatibility rather than adding a second medicine without evidence.
Review clinically assisted hydration and feeding against thirst, comfort, oedema, aspiration and secretion at least daily.
Ask family what they understand and whether the explanation and bedside plan have reduced fear.
Inspect any subcutaneous site and pump for delivery failure before declaring the medicine ineffective.

10Special situationsVariants, exceptions and circumstances that change the usual approach.

The sound can exceed suffering

Families may experience intense alarm while a deeply unconscious patient shows no behavioural or physiological distress.

Prevention is easier than clearance

Antimuscarinics reduce newly produced fluid and cannot dry a large volume already pooled in the airway.

Mouth care outranks dryness

Reducing secretion at the cost of an uncomfortably dry mouth defeats the symptom goal and requires reassessment.

Suction can worsen the cycle

Deep instrumentation irritates mucosa, causes bleeding and stimulates further fluid while removing only a temporary visible component.

Central effects vary by drug

Glycopyrronium and hyoscine butylbromide penetrate the brain less than hyoscine hydrobromide, influencing delirium choice.

Family explanation is clinical care

Accurate language, demonstration and repeated reassurance can provide more benefit than escalating a medicine with uncertain acoustic effect.

11Common pitfallsFrequent interpretation and management errors.

01
Calling every noisy breath an expected death rattle.
02
Describing the sound as choking or drowning without clinical evidence.
03
Using deep suction routinely in a dying unconscious person.
04
Starting several antimuscarinics at the same time.
05
Expecting medicine to remove fluid already present.
06
Treating noise while ignoring pain, breathlessness, oedema or infection.
07
Continuing clinically assisted hydration without reviewing secretion and comfort.
08
Escalating glycopyrronium through renal decline without retention and toxicity review.
09
Defining success as silence rather than comfort and family understanding.
10
Forgetting pump compatibility and subcutaneous-site assessment.